These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Hybrid genes between HLA-A2 and HLA-A3 constructed by in vivo recombination allow mapping of HLA-A2 and HLA-A3 polymorphic antigenic determinants. Sire J, Chimini G, Boretto J, Toubert A, Kahn-Perles B, Layet C, Sodoyer R, Lemonnier F, Jordan B. J Immunol; 1988 Apr 01; 140(7):2422-30. PubMed ID: 2450922 [Abstract] [Full Text] [Related]
11. Differential immunogenicity of HLA mismatches: HLA-A2 versus HLA-A28. Dankers MK, Roelen DL, Van Der Meer-Prins EM, De Lange P, Korfage N, Smits JM, Persijn GG, Welsh KI, Doxiadis II, Claas FH. Transplantation; 2003 Feb 15; 75(3):418-20. PubMed ID: 12589169 [Abstract] [Full Text] [Related]
15. Topographic map of the HLA-A2 CREG epitopes using human alloantibody probes. Fuller AA, Trevithick JE, Rodey GE, Parham P, Fuller TC. Hum Immunol; 1990 Jul 15; 28(3):284-305. PubMed ID: 1695623 [Abstract] [Full Text] [Related]
16. Changes in conformation with loss of alloantigenic determinants of a histocompatibility antigen (HLA-B7) induced by monoclonal antibodies. Parham P. J Immunol; 1984 Jun 15; 132(6):2975-83. PubMed ID: 6202768 [Abstract] [Full Text] [Related]